Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

NCT02030301 ↗

Phase 1/2 Completed 165 enrolled Vical

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to test the safety and effectiveness of two experimental therapeutic vaccines against herpes simplex virus, type 2 (HSV-2).

Timeline

Start: 2013-12
Primary completion: 2015-06
Completion: 2016-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VCL-HB01	Vaccine	0.25 ml	Intramuscular
Subject	VCL-HB01	Vaccine	0.5 ml	Intramuscular
Subject	VCL-HB01	Vaccine	1 ml	Intramuscular
Subject	VCL-HM01	Vaccine	1 ml	Intramuscular

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Summary

Timeline

Drugs

Indications